Treatment of adult T-cell leukemia/lymphoma: past, present, and future (Q37032793)

17 August 2017

1 reference

title

Treatment of adult T-cell leukemia/lymphoma: past, present, and future (English)

1 reference

adult T-cell leukemia/lymphoma

17 August 2017

1 reference

1 reference

Kenji Ishitsuka

1

1 reference

PubMed ID

18081707

17 August 2017

Kazuo Tamura

series ordinal

2

1 reference

17 August 2017

10 December 2007

1 reference

European Journal of Haematology

17 August 2017

1 reference

17 August 2017

80

1 reference

17 August 2017

3

1 reference

17 August 2017

185-196

1 reference

Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma

17 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

HLA-A*26, HLA-B*4002, HLA-B*4006, and HLA-B*4801 alleles predispose to adult T cell leukemia: the limited recognition of HTLV type 1 tax peptide anchor motifs and epitopes to generate anti-HTLV type 1 tax CD8(+) cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Cellular immune response to HTLV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Human T cell leukemia virus type I-induced disease: pathways to cancer and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

The prevalence of human T-cell leukemia virus type I infection in patients with hematologic and nonhematologic diseases in an adult T-cell leukemia-endemic area of Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Effect of human T-lymphotropic virus type I infection on non-Hodgkin's lymphoma incidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Infectious Complications in Patients with Adult T-Cell Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Human T-cell leukemia virus type I tax protein induces the expression of anti-apoptotic gene Bcl-xL in human T-cells through nuclear factor-kappaB and c-AMP responsive element binding protein pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Proliferation of adult T cell leukemia/lymphoma cells is associated with the constitutive activation of JAK/STAT proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Human T-cell leukemia virus type 1 tax dysregulates beta-catenin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Successful treatment of a patient with adult T-cell leukemia by daily oral administration of low-dose etoposide. Decrease in the amount of HTLV-I proviral DNA revealed by the polymerase chain reaction method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Treatment of adult T-cell leukemia/lymphoma with MST-16, a new oral antitumor drug and a derivative of bis(2,6-dioxopiperazine). The MST-16 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Treatment of adult T-cell leukaemia-lymphoma with irinotecan hydrochloride (CPT-11). CPT-11 Study Group on Hematological Malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Isolated central nervous system involvement in adult T-cell lymphoma/leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Arsenic trioxide induces apoptosis in human T-cell leukemia virus type 1- and type 2-infected cells by a caspase-3-dependent mechanism involving Bcl-2 cleavage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Recombinant interferon beta and gamma in the treatment of adult T-cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Interferon-alpha therapy following autologous peripheral blood stem cell transplantation for adult T cell leukemia/lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Huge mass of cutaneous-type adult T-cell leukemia which responded to interferon gamma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Anti-viral and immunomodulatory effects of interferon-alpha on cultured lymphocytes from patients with human T lymphotropic virus type I-associated myelopathy (HAM/TSP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Decreased human T lymphotropic virus type I (HTLV-I) provirus load and alteration in T cell phenotype after interferon-alpha therapy for HTLV-I-associated myelopathy/tropical spastic paraparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Th1/Th2 balance and HTLV-I proviral load in HAM/TSP patients treated with interferon-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Poor outcome of autologous stem cell transplantation for adult T cell leukemia/lymphoma: a case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia/lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Survey of anti-human T-cell leukemia virus type I antibody in family members of patients with adult T-cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Allogeneic bone marrow transplantation from unrelated human T-cell leukemia virus-I-negative donors for adult T-cell leukemia/lymphoma: retrospective analysis of data from the Japan Marrow Donor Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia/lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

New therapeutic approaches for adult T-cell leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Interferon alpha and zidovudine therapy in adult T-cell leukaemia lymphoma: response and outcome in 15 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

A prospective phase II clinical trial with the use of zidovudine and interferon-alpha in the acute and lymphoma forms of adult T-cell leukemia/lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Evidence against a direct cytotoxic effect of alpha interferon and zidovudine in HTLV-I associated adult T cell leukemia/lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Correlation of telomerase activity with development and progression of adult T-cell leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Transcriptional activation of hTERT through the NF-kappaB pathway in HTLV-I-transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Telomerase activity and telomere length as prognostic factors of adult T-cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Cyclic induction of senescence with intermittent AZT treatment accelerates both apoptosis and telomere loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Azidothymidine induces apoptosis and inhibits cell growth and telomerase activity of human parathyroid cancer cells in culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Telomerase Inhibition Using Azidothymidine in the HT-29 Colon Cancer Cell Line

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Regression of oral Kaposi's sarcoma in a case of AIDS on zidovudine (AZT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Azidothymidine inhibits NF-kappaB and induces Epstein-Barr virus gene expression in Burkitt lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Effect of lamivudine on transmission of human T-cell lymphotropic virus type 1 to adult peripheral blood mononuclear cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Susceptibility of human T cell leukemia virus type 1 to reverse-transcriptase inhibitors: evidence for resistance to lamivudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

The effect of antiretroviral therapy on HTLV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Zidovudine plus lamivudine in Human T-Lymphotropic Virus type-I-associated myelopathy: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

The molecular pathogenesis of acute promyelocytic leukaemia: implications for the clinical management of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Arsenic trioxide inhibits growth of human T-cell leukaemia virus type I infected T-cell lines more effectively than retinoic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Arsenic trioxide induces apoptosis in HTLV-I infected T-cell lines and fresh adult T-cell leukemia cells through CD95 or tumor necrosis factor alpha receptor independent caspase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Arsenic/interferon specifically reverses 2 distinct gene networks critical for the survival of HTLV-1-infected leukemic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Emodin and DHA potently increase arsenic trioxide interferon-alpha-induced cell death of HTLV-I-transformed cells by generation of reactive oxygen species and inhibition of Akt and AP-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed/refractory adult T-cell leukemia/lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Cytokine induction in HTLV-I associated myelopathy and adult T-cell leukemia: Alternate molecular mechanisms underlying retroviral pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Durable hematologic complete response and suppression of HTLV-1 viral load following alemtuzumab in zidovudine/IFN-{alpha}-refractory adult T-cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Complete response in a patient with adult T-cell leukemia (ATL) treated with combination of alemtuzumab and pentostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Frequent expression of CCR4 in adult T-cell leukemia and human T-cell leukemia virus type 1-transformed T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

The CC chemokine receptor 4 as a novel specific molecular target for immunotherapy in adult T-Cell leukemia/lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Retinoic acids induce growth inhibition and apoptosis in adult T-cell leukemia (ATL) cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

NIK-333 inhibits growth of human T-cell leukemia virus type I-infected T-cell lines and adult T-cell leukemia cells in association with blockade of nuclear factor-kappaB signal pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Reactive oxygen species mediate N-(4-hydroxyphenyl)retinamide-induced cell death in malignant T cells and are inhibited by the HTLV-I oncoprotein Tax.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

All-trans retinoic acid reduced skin involvement of adult T-cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Successful use of etretinate for long-term management of a patient with cutaneous-type adult T-cell leukaemia/lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

A mechanism of apoptosis induced by all-trans retinoic acid on adult T-cell leukemia cells: a possible involvement of the Tax/NF-kappaB signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Low-dose bexarotene and low-dose interferon alfa-2b for adult T-cell leukemia/lymphoma associated with human T-lymphotropic virus 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

HTLV-I tax induces cellular proteins that activate the kappa B element in the IL-2 receptor alpha gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Efficacy and mechanism of action of the proteasome inhibitor PS-341 in T-cell lymphomas and HTLV-I associated adult T-cell leukemia/lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Proteasome inhibitor, bortezomib, potently inhibits the growth of adult T-cell leukemia cells both in vivo and in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Induction of heme oxygenase-1 by cobalt protoporphyrin enhances the antitumour effect of bortezomib in adult T-cell leukaemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Bortezomib therapy in patients with relapsed or refractory lymphoma: potential correlation of in vitro sensitivity and tumor necrosis factor alpha response with clinical activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Expression of parathyroid hormone-related protein in a human T cell lymphotrophic virus type I-infected T cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Constitutive expression of parathyroid hormone-related protein gene in human T cell leukemia virus type 1 (HTLV-1) carriers and adult T cell leukemia patients that can be trans-activated by HTLV-1 tax gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Macrophage inflammatory protein-1alpha induces hypercalcemia in adult T-cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Clinical practice. Hypercalcemia associated with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

AZT inhibits the transmission of human T cell leukaemia/lymphoma virus type I to adult peripheral blood mononuclear cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

Treatment of Adult T-Cell Leukemia-Lymphoma with Zidovudine and Interferon Alfa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.01016.X

10.1111/J.1600-0609.2007.01016.X

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

18081707